BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...

But BCG is also used to treat bladder cancer. Research published today (June 5) in Science Translational Medicine reveals how BCG achieves its cancer-fighting performance, and suggests the bug has a ...

Within this BCG-Unresponsive cohort, if left untreated, approximately 40% of CIS patients risk progression to MIBC within five years – ultimately leading to bladder removal. In addition ...

therapy for patients with BCG-unresponsive nonmuscle-invasive bladder cancer (NMIBC) (). In an international study involving 299 patients with BCG-unresponsive NMIBC across 10 centers, 204 ...

The California biotech said it had not been ... There are few treatment options for patients who develop BCG-unresponsive bladder cancer, which raises the risk of the cancer spreading throughout ...

Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis live, attenuated culture preparation; 50mg per vial; pwd for intravesical administration after reconstitution and dilution ...

“Patients with BCG-naïve high-risk non-muscle invasive bladder cancer have high rates of recurrence and progression,” said Neal Shore, M.D., FACS, Medical Director for the Carolina Urologic ...